Cranial Cruciate Ligament Rupture

Cranial cruciate ligament rupture (CCLR) is a common and debilitating orthopedic condition in dogs, characterized by partial or complete tearing of the cranial cruciate ligament (CrCL) within the stifle (knee) joint. The CrCL is a primary stabilizer of the stifle, preventing cranial translation of the tibia relative to the femur, limiting internal rotation, and preventing hyperextension. Rupture leads to instability, inflammation, pain, and progressive degenerative joint disease (DJD). The condition is classified as traumatic (acute) or degenerative (chronic, often bilateral), with the latter being more common in dogs. Surgical management is often recommended to restore stability and mitigate long-term osteoarthritis.

The etiology of CCLR is multifactorial. In dogs, the most common cause is degenerative failure of the ligament due to repetitive microtrauma, conformational abnormalities (e.g., tibial plateau angle > 25 degrees), and genetic predisposition. Traumatic rupture can occur from sudden twisting, jumping, or direct impact, but is less common. Other contributing factors include obesity, immune-mediated arthritis, and previous meniscal injury. In cats, traumatic rupture is more frequent, often associated with high-rise syndrome or vehicular trauma. Iatrogenic causes are rare but can occur during stifle arthrotomy or arthroscopy.

CCLR is the most common orthopedic injury in dogs, accounting for approximately 20-40% of all canine orthopedic referrals. It affects both sexes equally, with a higher incidence in middle-aged to older dogs (5-7 years). Large and giant breeds (e.g., Labrador Retrievers, Golden Retrievers, Rottweilers, and Mastiffs) are overrepresented, but small breeds (e.g., Yorkshire Terriers, Bichon Frises) can also be affected. Bilateral disease occurs in 30-40% of cases, with the contralateral limb often rupturing within 1-2 years. Neutered dogs have a higher risk, possibly due to hormonal influences on ligament structure. Working and athletic dogs are at increased risk due to high physical demands.

The CrCL is composed of two functional bands: the craniomedial band, which is taut in both flexion and extension, and the caudolateral band, which is taut only in extension. Degenerative rupture begins with loss of collagen fiber organization, decreased cellularity, and chondroid metaplasia, leading to weakening and eventual tearing. This degeneration is often bilateral and progressive. Once ruptured, the stifle becomes unstable, allowing cranial tibial thrust during weight bearing. This instability leads to synovitis, meniscal damage (especially the medial meniscus), and progressive osteoarthritis. Inflammatory mediators, such as matrix metalloproteinases and cytokines, further degrade articular cartilage. The menisci, particularly the medial meniscus, are often crushed or torn due to the abnormal shear forces, exacerbating pain and dysfunction.

Intrinsic factors include breed (large breeds), age (middle-aged), obesity, and conformational abnormalities such as a steep tibial plateau angle, patellar luxation, and angular limb deformities. Genetic factors are suspected, with certain lines having higher incidence. Extrinsic factors include trauma, excessive activity, poor physical conditioning, and nutritional imbalances (e.g., overfeeding during growth). Prior contralateral CCLR is a significant risk factor for the other limb. Additionally, immune-mediated joint disease and endocrine disorders (e.g., hypothyroidism) may predispose to ligament degeneration.

Clinical signs vary from acute non-weight-bearing lameness to chronic intermittent lameness. On physical examination, affected dogs may show muscle atrophy, joint effusion, and pain on stifle manipulation. The hallmark sign is a positive cranial drawer test, where the tibia can be translated cranially relative to the femur. A tibial compression test (Tibial Thrust Test) is also positive. In chronic cases, crepitus and thickening of the joint capsule may be present. Meniscal injury may cause a clicking sound during manipulation. Bilateral disease may present with bilateral hindlimb lameness or a crouched stance. Systemic signs are rare but may include fever if septic arthritis is present.

Differential diagnoses include: (1) Patellar luxation, especially medial luxation in small breeds, which can be differentiated by palpation and radiography. (2) Meniscal injury without CCLR, which is rare but can be diagnosed via arthroscopy or MRI. (3) Stifle osteoarthritis from other causes, such as osteochondritis dissecans (OCD), which is more common in young large breeds. (4) Fractures of the distal femur or proximal tibia, which are usually traumatic and evident on radiographs. (5) Septic arthritis, which presents with severe pain, swelling, and systemic signs, and is confirmed by synovial fluid analysis. (6) Immune-mediated polyarthritis, which affects multiple joints and responds to immunosuppressive therapy. (7) Neoplasia, such as synovial cell sarcoma, which is rare but can be identified by imaging and biopsy. (8) Spinal cord disease, such as intervertebral disc disease, which may cause hindlimb weakness but lacks stifle instability.

The diagnostic algorithm begins with a thorough history and physical examination, including orthopedic and neurological assessments. The cranial drawer test and tibial compression test are performed under sedation or anesthesia to confirm instability. Radiography is the next step, including standard lateral and craniocaudal views, to assess joint effusion, osteoarthritis, and to measure the tibial plateau angle (TPA) for surgical planning. Stress radiography (e.g., tibial compression view) can document instability. Advanced imaging, such as MRI or CT, is reserved for cases with suspected meniscal injury or concurrent pathology. Arthroscopy is the gold standard for evaluating the intra-articular structures and can be both diagnostic and therapeutic. If surgery is planned, a complete blood workup and urinalysis are performed to assess anesthetic risk.

Synovial fluid analysis is crucial: in CCLR, the fluid is typically non-inflammatory to mildly inflammatory, with a nucleated cell count of 1,000-10,000 cells/µL, predominantly mononuclear cells, and good mucin clot quality. In chronic cases, the fluid may be xanthochromic. Hematology and biochemistry are usually unremarkable, but may show mild elevations in inflammatory markers (e.g., C-reactive protein). Coagulation panel (PT/aPTT) is recommended before surgery, especially if nonsteroidal anti-inflammatory drugs (NSAIDs) are used. Blood gas analysis is not routinely needed but may be useful in trauma cases. Urinalysis is performed to rule out urinary tract infection, which could increase the risk of implant infection.

Radiography: Standard lateral and craniocaudal views of the stifle are essential. Findings include joint effusion (cranial displacement of the infrapatellar fat pad), periarticular osteophytes, and subchondral sclerosis. The tibial plateau angle (TPA) is measured on a true lateral radiograph; a TPA > 25 degrees is considered a risk factor. Stress radiography (tibial compression view) can demonstrate cranial tibial translation. Ultrasonography: Can be used to assess the CrCL and menisci, but is operator-dependent and less sensitive than MRI. CT: Provides detailed bone morphology and is useful for surgical planning, especially for TPLO, but has limited soft tissue resolution. MRI: Excellent for evaluating the CrCL, menisci, and articular cartilage; it can detect partial tears and meniscal injuries. Arthroscopy: Allows direct visualization of the CrCL, menisci, and cartilage, and can be used for minimally invasive treatment.

Synovial fluid cytology typically shows a low to moderate nucleated cell count with a predominance of large mononuclear cells and occasional neutrophils. No infectious agents are seen. Histopathology of the ruptured CrCL shows degenerative changes: loss of collagen fiber orientation, chondroid metaplasia, and calcification. If a meniscal tear is present, histopathology of the meniscus may show fibrocartilaginous degeneration. In cases with concurrent osteoarthritis, articular cartilage biopsy may show fibrillation and loss of proteoglycans. These findings are not specific but support the diagnosis.

Treatment is primarily surgical, especially in large breed dogs and active patients. Conservative management (rest, weight control, NSAIDs, and physical therapy) may be considered for small dogs (<15 kg) with partial tears and minimal instability, but surgery is recommended for optimal long-term function. Surgical options include: (1) Extracapsular stabilization (e.g., lateral fabellar suture) using heavy monofilament nylon or polyethylene suture, which is simple and cost-effective but less stable in large dogs. (2) Tibial plateau leveling osteotomy (TPLO) - a curved osteotomy of the proximal tibia to reduce tibial thrust, which is the gold standard for large dogs. (3) Tibial tuberosity advancement (TTA) - a cranial advancement of the tibial tuberosity to neutralize the patellar tendon angle. (4) Cranial cruciate ligament repair (intracapsular) - using a graft (e.g., patellar tendon) to replace the ligament, but is less commonly performed. (5) In cats, extracapsular repair is often sufficient. Meniscal tears are addressed via partial meniscectomy or meniscal release. Postoperative management includes pain control, cold therapy, and a structured rehabilitation program. Implants (e.g., plates and screws for TPLO) are chosen based on patient size and surgeon preference.

The prognosis is generally good to excellent with surgical treatment, especially if meniscal damage is addressed. Approximately 85-90% of dogs return to acceptable function within 6-12 months. However, progression of osteoarthritis is inevitable, and long-term management may be needed. Complications include implant failure, infection, patellar luxation, and meniscal injury. Negative prognostic indicators include severe osteoarthritis, obesity, and delayed surgical intervention. In cats, the prognosis is excellent with surgical repair.

Postoperative follow-up is critical. Sutures are removed at 10-14 days. Radiographs are taken at 4, 8, and 12 weeks to assess bone healing (for TPLO/TTA) and implant position. Restricted activity (leash walks only) is advised for 8-12 weeks, with gradual return to normal activity. Physical therapy, including passive range of motion exercises and swimming, is initiated at 2-4 weeks. Long-term monitoring includes annual radiographs to assess osteoarthritis progression and joint function. Weight management is essential. If the contralateral limb becomes lame, it should be evaluated for CCLR.

Pearls: (1) Always perform a cranial drawer test under sedation to avoid false negatives. (2) In chronic cases, the drawer may be less pronounced due to periarticular fibrosis; use the tibial compression test. (3) During TPLO, preserve the patellar tendon and avoid iatrogenic fracture of the tibial tuberosity. (4) Always explore the medial meniscus for tears; if a tear is present, perform a partial meniscectomy. (5) Use a postoperative rehabilitation protocol to improve outcomes. Pitfalls: (1) Failure to diagnose partial tears, which may progress to complete rupture. (2) Inadequate implant placement leading to instability. (3) Overlooking concurrent patellar luxation or other stifle pathologies. (4) Excessive postoperative activity causing implant failure. (5) Not addressing obesity, which increases the risk of contralateral rupture.

Perioperative antimicrobial prophylaxis: Cefazolin (22 mg/kg IV) administered 30 minutes before incision and repeated every 90 minutes during surgery. Postoperative analgesia: Opioids such as hydromorphone (0.05-0.1 mg/kg IV or IM q4-6h) or fentanyl CRI (2-5 µg/kg/h) for 12-24 hours. NSAIDs: Carprofen (2.2 mg/kg PO q12h) or meloxicam (0.1 mg/kg PO q24h) for 3-7 days, with caution in patients with renal or hepatic disease. Local anesthesia: Femoral and sciatic nerve blocks with bupivacaine (1-2 mg/kg) or lidocaine (2-4 mg/kg) can provide intraoperative and postoperative analgesia. Muscle relaxants: Methocarbamol (15-20 mg/kg PO q8h) may be used for muscle spasms. Chondroprotectants: Polysulfated glycosaminoglycan (Adequan) 4.4 mg/kg IM or SC twice weekly for 4 weeks, or oral glucosamine/chondroitin supplements. For chronic pain, amantadine (3-5 mg/kg PO q24h) may be added. Always adjust dosages for renal/hepatic impairment and monitor for adverse effects.

Landmark studies include the work by Slocum and Devine (1984) introducing TPLO, which has become the standard of care for large dogs. A prospective study by Boudrieau et al. (2005) compared TPLO and lateral fabellar suture, showing superior long-term function with TPLO in large breeds. The Tibial Tuberosity Advancement (TTA) was introduced by Montavon et al. (2002) and has shown comparable outcomes to TPLO in some studies. A meta-analysis by Bergh et al. (2014) concluded that both TPLO and TTA provide good outcomes, but TPLO may have a lower complication rate. The importance of meniscal management was highlighted by Ralphs and Whitney (2002), who found that meniscal release can reduce the risk of subsequent meniscal tears. Consensus guidelines from the ACVS and ECVS recommend surgical stabilization for most dogs with CCLR, with a focus on early intervention and rehabilitation.